Abstract:International Journal of Stroke, Ahead of Print. Background:Hyperglycemia is associated with worse stroke outcomes, but it is uncertain whether tight glycemic control during the acute stroke period is associated with a better outcome. We conducted a meta-analysis to compare the effect of tight glycemic control versus loose glycemic control in the acute phase of stroke patients.Methods:A literature search was performed to identify randomized controlled trials comparing the safety and efficacy of tight glycemic control with a relatively loose control of blood glucose of acute stroke (ischemic or hemorrhagic) patients within 24 h after stroke onset. We required that the blood glucose level of the patients should not be lower than 6.11 mmol/L at the time of enrollment, and for the intensive blood glucose control range, we defined the blood glucose level as lower than that of the control group. The primary efficacy outcome measure was deaths from any cause at 90 days. Secondary efficacy outcomes comprised the number of participants with modified Rankin score (mRS). We define mRS scores 0–2 as favorable scores, recurrent stroke, and the National Institute of Health Stroke Scale or the European Stroke Scale scores. We defined the number of participants with hypoglycemia as our primary safety outcome. Subgroup analysis was performed according to age, the variety of interventions, maintained glucose level, and status of hypoglycemia on National Institute of Health Stroke Scale (NIHSS) scores or European Stroke Scale (ESS) scores.Results:Fifteen randomized controlled trials (RCTs) with 2957 participants meeting the including criteria were identified and included in this meta-analysis, although not all included data on every outcome measure. Data on the primary efficacy endpoint, mortality at 90 days, was available in 11 RCTs, a total of 2575 participants. There was no significant difference between the intervention and control groups (odds ratio (OR): 1.00; 95% confidence interval (CI): 0.81–1.23; P = 0.99). For secondary endpoints, there was no difference between intervention and control groups for a mRS from 0 to 2 (OR: 0.96; 95% CI: 0.80–1.15; P = 0.69; data from 9 RCTs available), or recurrent stroke (OR: 1.34; 95% CI: 0.92–1.96; P = 0.13; data from 3 RCTs available). For NIHSS scores or ESS scores, there was a small difference in favor of intensive controls (standardized mean difference: −0.29; 95% CI: −0.54 to −0.04; P = 0.02). There was a marked increase in hypoglycemia with tight control: (OR of 9.46 (95% CI: 4.59–19.50; P < 0.00001; data from 9 RCTs available).Conclusion:There was no difference between tight and loose glycemic control on mortality, independence, or recurrent stroke outcome in acute stroke, but an increase in hypoglycemia. There was a small effect improvement on neurological scales, but the relevance of this needs to be confirmed in future adequately powered studies.

Intensive Versus Conventional Insulin Therapy in Stroke (a Meta-analysis)

Intensive versus conventional insulin therapy in severe traumatic brain injury: a Meta -analysis

The study of intensive insulin versus standard insulin for prognosis in patients with acute cerebral infarction and post stroke hyperglycemia

Intensive Insulin Therapy for Septic Patients: A Meta-Analysis of Randomized Controlled Trials

Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis.

Abstract WP378: Insulin in the Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

[The Influence of Intensive Insulin Therapy on the Mortality of Critically Ill Patients in Intensive Care Unit: a Meta-Analysis].

Meta-analysis of the therapeutic effects of insulin on neurological impairment of patients with acute cerebral infarction

Meta-analysis of Safety and Efficacy of 2 Insulin Therapy in Stress Hyperglycemia Patients

[Effect of Intensive Insulin Therapy on Prognosis in Patients With Acute Myocardial Infarction].

Intensive Insulin Therapy vs.Routine Therapy for Patients with Non-insulin-dependent Diabetes Mellitus:Evaluation of Physiological Indexes and Subjective Experience Indexes

Safety and efficacy of tight versus loose glycemic control in acute stroke patients: A meta-analysis of randomized controlled trials

Hyperglycemic control in acute ischemic stroke patients undergoing endovascular treatment: post hoc analysis of the Stroke Hyperglycemia Insulin Network Effort trial

Impact of insulin therapy to control blood glucose on different levels on criticaly ill patients

Abstract WMP3: Hyperglycemic Control In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: Post-hoc Analysis Of Stroke Hyperglycemia Insulin Network Effort Trial

Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes Following the First Episode of Cerebral Infarction

Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes

Effect of Intensive Insulin Therapy on Cerebrospinal Fluid Lactic Acid Metabolism in Patients with Severe Head Injury

Meta-analysis on antihypertensive treatment for the acute-phase stroke on prognosis outcome in China

Intensive Versus Conventional Glucose Control In Critically Ill Patients: A Meta-Analysis Of Randomized Controlled Trials